Cannabinoids And The Cholinergic System by Domino, Edward F.
J Clin Pharmacol. 1981; 21:249S-255S.
249S
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EDWARD F. DOMINO, M.D., Ann Arbor, Mich.
Abstract: 9-Tetrahyd rocannabinol (THC) decreases EEG activation and causes slow
waves in the cat. The EEG slow-wave activity is accompanied by a concomitant
decrease in acetylcholine release from the neocortex. The findings suggest that THC
depresses the brain stem activating system. Large doses of and -THC increase
brain acetylcholine levels in rodents such as the mouse and rat, but this effect is not
seen with minimal doses of the cannabinoids which show behavioral effects. The most
dramatic change produced by THC is that brain acetylcholine utilization is reduced
primarily in the hippocampus.
I T is still far from clear how cannabinoids
produce their remarkable pharmacologic
effects. The cannabinoids interact with
many different neuronal and biochemical
systems,”2 but which action is the most im-
portant in relation to therapeutic effects is
still unknown. Marihuana and z9-tetra-
hydrocannabinol (THC) have remarkable
effects on human memory and cogthfion.’
Recently, Ferraro6 has reviewed the exten-
sive literature on this subject. Although
marihuana’s acute effects on memory vary,
he concluded that they are always detri-
mental to the marihuana user. Our animal
neurochemical research suggests that these
undesirable side effects of cannabis and
probably other synthetic cannabinoids are
related to a decrease in the release of neuro-
nal acetylcholine (ACh) and its turnover in
certain regions of the brain. This report
summarizes these results from our labora-
tory. It should be pointed out that at least
three other laboratories in the United
States have been active in this field.7 The
results from all four laboratories differ in
details, but all agree that cannabis prepa-
rations interact with the cholinergic sys-
tem. Cannabinoids, especially the 7-OH de-
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rivatives, inhibit the twitch response of the
guinea pig ileum to electric field stimula-
tion,’#{176}a finding consistent with an ACh
antirelease effect either indirectly or di-
rectly. There are a number of prominent
side effects of cannabinoids in humans that
also suggest an interaction with the cholin-
ergic system, including dry mouth, tachy-
cardia and bradycardia, drowsiness, seda-
tion, and short-term memory loss.
Methods
Mice, rats, and cats have been used in
this research; details of the methods em-
ployed have been published elsewhere.”’6
Briefly, a large variety of acetylcholine
(ACh) assay techniques have been used in-
cluding bioassays such as the frog rectus
abdominus and the leech muscle, and
chemical assays including the enzymatic
choline kinase method, pyrolysis and
chemical demethylation, gas chromatogra-
phy-flame ion detection (GC-FID), gas
chromatography-nitrogen detection (GC-
ND), and gas chromatography-mass spec-
trometry (GC-MS). Current results, obtained
using chemical demethylation and GC-ND
or GC-MS, are fully consistent with the re-
sults obtained using bioassay and chemical
assay techniques.
TABLE I





Effects of Cannabinoids on Neocortical
Acetylcholine Release in the Cat
Inasmuch as wakefulness involves a
brain stem activating mechanism in the re-
ticular formation and hypothalamus which
has widespread neocortical and limbic sys-
tem effects, it was postulated that THC
would affect these systems. Both EEG and
acetylcholine (ACh) release data were ob-
tained to indicate that this indeed is the
case.” It is known that the level of spon-
taneous release of ACh from the neocortex
varies with the degree of anesthesia and
level of brain stem transection. In order to
assure a high level of spontaneous release,
pretrigeminal brain stem transected prepa-
rations were used. Usually, the mean of
three assays before and after drug adminis-
tration was obtained. In our animals, the
range in baseline release varied from a low
of 8.0 to a high of 51.4 ng/cm’/lO mm, with
a mean ± S.E. for 24 animals before drug of
22.9 ± 2.2 ng/cm’/lO mm 3 hours after hal-
othane anesthesia and brain stem transec-
tion. The factors involved in the wide range
observed in baseline release of ACh proba-
bly include residual anesthesia and post-
surgical brain trauma.
THC in intravenous doses of 0.5 to 11.0
mg/kg produced high-voltage slow waves
in the EEG of the neocortex of pretrigemi-
nal midpontine transected cats. EEG high-
voltage slow waves were more prominent in
the frontal than the occipital cortical leads.
The left frontal cortical lead which con-
tained the bathing solution for collecting
ACh showed EEG spikes and slow waves
typical of the local effects of physostig-
mine. Small doses of THC tended to exag-
gerate these effects, but in larger doses they
were reduced. The administration of (+)-
amphetamine in intravenous doses of 2.5
mg/kg dramatically antagonized most of
the effects induced by THC. Small doses of
THC in the order of 0.5 mg/kg produced
variable effects on ACh release. Some












release, while others showed a slight de-
crease. However, larger doses of THC pro-
duced consistent and progressively greater
depression of ACh release. These effects are
antagonized by (+)-amphetamine (Table!).
The mean ± S.E. acetyicholine concen-
tration in rat brain for 12 control animals
given no injection was 25.3 ± 0.8 nmole/-
Gm. Thirty minutes after Tween vehicle
alone was given to 11 rats, brain ACh was
26.4 ± 1.3 nmole/Gm. This value was not
significantly different from that achieved
after no injection. After 1 g acetylseco
HC-3 (ASHC-3) was administered intra-
ventricularly in 13 animals, brain ACh was
significantly reduced to 20.3 ± 0.9 nmole
/Gm (P < 0.001). When THC was given
alone in doses of 3.2, 10, and 32 mg/kg in-
traperitoneally 30 minutes later, only the
largest dose caused a significant increase
in brain ACh above control (P < 0.05).
Doses of THC of 5 mg/kg intravenously
and 10mg/kg intraperitoneally 1 hour later
also did not significantly affect total brain
ACh. On the other hand, in animals pre-
treated with ASHC-3, doses of 10 and 30
mg/kg THC intraperitoneally significant-
ly elevated brain ACh to control levels (P <
0.001), indicating that ACh utilization was
reduced.
Similar findings were observed in mouse
brain in which 3.2 ig ASHC-3 was given
intraventricularly. None of the control ve-
hicles had any significant effect on mouse
brain ACh 30 minutes later, whereas
tsarI - #{149}I I I #{149} #{149}#{149} I
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Mean ± SE. P5Subcutaneoust Intraventricular
Vehicle” 8 18.6 ± 1.8
Vehicle NaBr 8 19.2 ± 2.0 NS
Vehicle ASHC-3 31 9.5 ± 0.5 <0.001
a9-THC, 10 mg/kg ASHC-3 8 11,5 ± 0.9 NS
-THC, 32 mg/kg ASHC-3 9 16,5 ± 1.3 <0.001
19-THC, 56 mg/kg ASHC-3 8 19.2 ± 2.0 <0.001
18-THC, 32 mg/kg ASHC-3 10 12.6 ± 1.7 <0.05
* Group comparison Student’s t-test.
4% Tween-20 in 0.9% saline,
t 3.2 mg, 30 minutes prior to sacrifice.
ASHC-3 reduced brain ACh levels signifi-
cantly(P <0.001). Both - and i9-THC sig-
nificantly reduced mouse brain ACh utili-
zation just as i9-THC did in the rat (Table
II).
Effects of THC on Regional Rat Brain
Acetyicholine Levels and Utilization
Inasmuch as whole-brain acetylcholine
(ACh) utilization was reduced by THC, it
seemed important to localize this effect. Be-
cause the method involves the intraven-
tricular injection of ASHC-3, brain areas
close to the ventricles (hippocampus, hypo-
thalamus, thalamus, and caudate) were
studied. Male Holtzman rats (six per group)
without intraventricular cannulation were
given either THC (10 mg/kg, intraperito-
neally) or vehicle and were sacrificed 1 hour
later by microwave irradiation. Only slight,
insignificant changes were found in the re-
gional levels of ACh (Fig. 1). In view of the





















Fig. 2. Effects of THC on regional brain acetyicholine utilization in the rat
brain. *** <0.01 group comparison Student’s t-test.
gional brain ACh levels, its effects on re-
gional brain ACh utilization were exam-
ined. Male Holtzman rats (six per group)
were given intraperitoneally 1.0 to 32
mg/kg THC suspended in 4% Tween 20-0.9%
NaC1 and sacrificed 1 hour later by focused
microwave irradiation. The procedure dif.
fered from that when using normal animals
in that polyethylene cannulas (PE1O) were
implanted under light ether anesthesia 48
hours prior to drug administration. Each
rat was implanted with an intraventricular
cannula 4.5 mm below the cranial surface.
Two days later, on the experimental day, 30
minutes before sacrifice, ASHC-3 (3.2 zg)
was injected into the left lateral ventricle
through the cannula. Acetylcholine levelsin
the hypothalamus, thalamus, hippocam-
pus, and the caudate nucleus were then as-
sayed (Fig. 2). No significant alteration of
ACh utilization was found in the hypothal-
amus, thalamus, or caudate nucleus. How-
ever, the previously depleted hippocampal
levels of ACh increased in a dose-effect
manner, ranging from 123 (1.0 mg/kg) to
243 per cent (32 mg/kg).
Discussion
Among the many neurochemical actions
of the cannabinoids is their effect on the re-
lease and turnover of acetylcholine. Whether
any of the potential therapeutic effects of
cannabinoids are related to a cholinergic
mechanism is certainly questionable. How-
ever, some of the potential undesirable side
effects of cannabinoids are almost cer-
tainly related to a decrease in ACh release
and turnover.
Large doses of 10 mg/kg or more of THC
elevate rat brain ACh and reduce its turn-
over. Inasmuch as doses of 3.2 mg/kg
THC already depress acquisition of rat
shuttle box behavior, the failure of this dose
to affect total rat brain ACh indicates a
dissociation of total brain ACh and THC
behavioral effects. Regional brain ACh
studies indicate that THC, in doses of 3.2
mg/kg intraperitoneally in rats, produces
localized hippocampal ACh effects.
Our finding of a decreased rat brain hip-
pocampal ACh turnover by THC suggests
that at least this neurochemical effect may
be related to an unwanted side effect of
cannabinoid administration. It would be of
great interest to examine other synthetic
cannabinoids such as nabilone and levo-
nantradol for similar effects. If these agents
also reduce short-term memory, they may
be of especial interest therapeutically to
anesthesiologists. If indeed these new can-
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nabinoids do affect short.term memory, it
would be of value to study their effects on
brain ACh release, content, utilization, and
turnover.
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Discussion of the Paper
Dr. Dewey: As Dr. Domino indicated, my
colleagues, Frank Vocci, Hem Tripathi and
I have been working on this problem as
well. We have studied the effects of 9 differ-
ent cannabinoids on acetylcholine turnover
in mice. The animals were sacrificed 20
minutes after intraperitoneal administra-
tion of the compounds. We found that 30
mg/kg of 9-THC (a dose which causes a
decrease in locomotor activity) decreases
acetylcholine turnover, as measured by the
radioenzymatic method of McCamman and
Goldberg. 11-Hydroxy-9-THC is more ac-
tive than the parent compound, and is also
more active in altering the behavior of
mice. The effect of 5-THC (30 mg/kg) is not
significantly different from control but is
significantly different from the 3 mg/kg
dose. In general we observed effects on ace-
tylcholine turnover similar to effects pre-
viously reported for other neurotransmitter
systems; i.e. low doses stimulate while high
doses depress the noradrenergic and do-
paminergic system. In slight contrast to Dr.
Domino’s results, cannabinol (10 and 30
mg/kg) depressed acetyicholine synthesis.
Cannabidiol was completely without effect.
$-HHC (synthesized by May and Wilson) at
30 mg/kg significantly decreased acetyl-
choline synthesis. The a-isomer, which has
neither analgetic nor significant psycho-
tomimetic effects, reduced acetylcholine
synthesis only at a dose of 100 mg/kg.
“Abnormal cannabidiol” (synthesized by
Razdan of SISA) was inactive even at doses
up to 100 mg/kg. 1-Methoxy-z8-THC, like
“abnormal cannabidiol” had minimal ef-
fect on the central nervous system below
doses of 100 mg/kg, at which dose it also
decreased the synthesis of acetylcholine.
Thus we concur with the hypothesis that, in
mice, cannabinoids lead to a decrease in
acetylcholine in the hippocampus which
may be related to psychotomimetic activ-
ity; however in 5 other brain areas there
were no other significant effects in mice
with any of these compounds.
Dr. Cash: Is it possible to measure acetyl-
choline release by monitoring spontaneous
miniature end-plate potentials in peripheral
muscle?
Dr. Domino: Yes. It is simple for the neu-
romuscular junction which is a nicotinic
cholinergic effect. However, patients tak-
ing marijuana or THC show mostly a mus-
carinic cholinergic response. The guinea
pig ileum has been used, but poor aqueous
solubility has prevented extensive study of
cannabinoids in this system. The most ef
fective cholinergic anti-release cannabi.
noids are the more water soluble OH-deriva-
tives.
Dr. Perez-Re yes: The first effect of mari-
juana in human beings is cerebral activa-
tion. Euphoria, increase in thought pro-
cesses, and increase of imagery and sensory
perception; all of these point to activation.
After this activation, the effect becomes
sedative, with the subject seeming to be
exhausted.
Dr. Domino: We have preliminary evi-
dence for a facilitating effect on cortical
acetylcholine release with very low doses of
THC. The number of experiments is small,
but the data are consistent with the clinical
observations.
Dr. Bra ude: Do you see the same effects
after chronic and acute administration? Do
you find comparable effects with phen-
cyclidine?
Dr. Domino: No, just the opposite. Phen-
cycidine is amphetamine-like in facilitat-
ing the turnover of acetylcholine. Unfortu-
nately, we don’t have any data following
chronic administration of THC, although I
would expect tolerance development.
Dr. Clark: In humans we found (Clark,
W.C., Goetz, R. R., McCarthy, R. H., Bern-
porad, B. and Zeidenberg, P. In G. G. Nahas
and W. D. M. Paton (Eds.) Marihuana: Bio.
logical Effects. Oxford: Pergamon Press,
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1979) only a slight effect on short-term mem-
ory; what was most disturbed was recall.
Information got in, and was stored, but the
subjects could not recall it unless we gave
them a hint. The difficulty with retrieval of
the information appeared to occur at an
early stage of the memory process. The sub.
jects failed to encode it in a systematic
manner into a memory trace. In going from
animal to human work we do not want to
look at the short-term memory side as much
as at the recall from longer term memory,
but I do not know how you do that in
animals.
Dr. Domino: That is precisely what
happens as we get older-we have trouble
with recall from memory. Thus I have been
interested in marijuana and other canna-
binoids as models of memory deficits in the
geriatric patient.
Dr. Mechoulam: With cannabidiol, Costa
showed that there is decrease in acetylcho-
line turnover. At my suggestion, he then
compared two optical isomers, only one of
which is psychotropically active, as well as
a much more potentdimethylheptyl analog.
The psychotropicallyinactive isomer caused
essentially no change in acetylcholine turn-
over. The psychotropically active com-
pound caused a large increase in acetylcho-
line turnover; so I think there is some
correlation between cannabinoid psychic
effects and acetylcholine turnover. (Re-
vuelta et al., Brain Research 195, 445, 1980).
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